Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey L. Henken who wrote (2152)	11/13/1998 1:39:00 PM
From: Grant MacMillan	Read Replies (2) \| Respond to of 2887

Well, the response from people has been interesting. I suppose I am on the more aggressive side of the forecasts. I do get the sense that there are other investors who expect more from the current product line than will likely be realized in the earnings. Jeff, you mention the selling of non-core technologies. Considering your own earnings projections, do you consider any of their current products on the market as being core, or is the OmniCath & Omnifilter the only products worth focusing on? Also, the $18MM offer from two years ago (sorry I don't know more about it), do you now consider their not accepting that offer a mistake, or were they after patents which would have left no future for ABMI? GM